Health Condition 1: E050- Thyrotoxicosis with diffuse goiter Health Condition 2: E052- Thyrotoxicosis with toxic multinodular goiter Health Condition 3: E051- Thyrotoxicosis with toxic single thyroid nodule
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Bhabani Sankar Dhal
Eligibility
Inclusion criteria
Inclusion criteria: premenopausal females and males aged 18–65 years, with newly detected hyperthyroidism were included in this study. The patients with hyperthyroidism had a diagnosis of Graves disease, Toxic MNG or Toxic adenoma. There were also age, sex, BMI matched healthy control groups who were euthyroid.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.to comapre BMD, bone turnover markers, fracture risk of newly diagnosed hyperthyroid patients with control 2. to compare the change in bone turnover markers after treatment with baseline 3. to compare the change in BMD, fracture risk after treatment with baseline Timepoint: 1.at baseline , 2. after 3 months of euthyroid state 3. 1 year after treatment for BMD and fracture risk | — |
Secondary
| Measure | Time frame |
|---|---|
| correlation of thyroid hormones with bone turnover markers at baselineTimepoint: at baseline before treatment | — |
Countries
India
Contacts
Public ContactBHABANI SANKAR DHAL
MKCG Medical College
Outcome results
None listed